GeneDx Holdings Corp. (WGS)

27.91 +0.17 (+0.61%) As of 09:30AM EDT. Market open.

GeneDx Holdings Corp.

North Tower
6th Floor 333 Ludlow Street
Stamford, CT 06902
United States
888 729 1206
https://www.genedx.com

Sector(s): Healthcare
Industry: Health Information Services
Full-time employees: 1,000

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Katherine A. Stueland	President, CEO & Director	745.91k	N/A	1976
Mr. Kevin Feeley	Chief Financial Officer	488.19k	N/A	1981
Ms. Karen Ponchner	Senior VP & Head of Operations	N/A	N/A	N/A
Mr. Eric Olivares Ph.D.	Chief Product & Technology Officer	N/A	N/A	N/A
Mr. Devin K. Schaffer J.D., M.B.A.	General Counsel	N/A	N/A	N/A
Mr. Paul Kruszka M.D.	Chief Medical Officer	N/A	N/A	N/A
Ms. Melanie Duquette	Chief Growth Officer	N/A	N/A	N/A
Sabrina Dunbar	Chief of Staff	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

Corporate governance

GeneDx Holdings Corp.’s ISS governance QualityScore as of 1 June 2024 is 10. The pillar scores are Audit: 10; Board: 8; Shareholder rights: 8; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.